All News #Library
Sciences
Viatris Presents Investigational Low-Dose Estrogen Contraceptive
01 May 2026 //
PR NEWSWIRE
Chiesi and Viatris Collaborate on BIO Video Series
28 Jul 2025 //
FIERCE PHARMA
Viatris To Participate In UBS And Jefferies Healthcare Conferences
29 Oct 2024 //
PR NEWSWIRE
Viatris Named to Forbes` World`s Top Companies for Women 2024 List
29 Oct 2024 //
PR NEWSWIRE
Viatris Named To Forbes` Annual List Of World`s Best Employers
08 Oct 2024 //
PR NEWSWIRE
Viatris Reveals Branding to Reflect New Company`s Transformative Strategy
08 Jul 2020 //
PRNEWSWIRE
More companies in talks for Remdesivir licence
15 May 2020 //
ECONOMICTIMES
Researchers from Intermountain Healthcare & UT Health Launch Two Vital COVID-19
08 Apr 2020 //
PRNEWSWIRE
Roche adapts newer breast cancer drug in face of Herceptin imitations
05 Feb 2019 //
REUTERS
Mylan and Biocon`s Trastuzumab Biosimilar Gains European Marketing Authorization
19 Dec 2018 //
CENTER FOR BIOSIM
Political Battle Over Fetal Tissue Could Force Closure of Research Center
06 Dec 2018 //
BIOSPACE
Coherus` newly minted Neulasta biosim steps up pressure on Amgen
06 Nov 2018 //
FIERCE PHARMA
Momenta calls time on biosimilar R&D, cuts half its staff
03 Oct 2018 //
FIERCE BIOTECH
Mylan Launches Authorized Generic of Ampyra® Tablets
21 Sep 2018 //
PR NEWSWIRE
Adamis Pharma’s EpiPen alternative succeeds in human factors study
06 Mar 2018 //
DRUG DELIVERY
VCCP Health wins record 10 Golds at PM Society Awards
05 Feb 2018 //
PHARMA TIMES
Baclofen: Controversial alcoholism drug stops man stuttering in chance CTRL
11 May 2017 //
IBTIMES
Drug Companies Under Investigation by Senate Possible Link to Opioid Epidemic
29 Mar 2017 //
SHAPE
Sarah Jessica Parker quits Mylan campaign `direct result` of EpiPen price hikes
26 Aug 2016 //
FIERCE PHARMA

Market Place
Sourcing Support